NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球泌尿外科器械市場-預測(2021-2026)

Global Urology Devices Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023167
出版日期 內容資訊 英文 115 Pages
商品交期: 最快1-2個工作天內
價格
全球泌尿外科器械市場-預測(2021-2026) Global Urology Devices Market - Forecasts from 2021 to 2026
出版日期: 2021年07月07日內容資訊: 英文 115 Pages
簡介

全球泌尿器械市場預計將從 2019 年的 282.13 億美元增長至 2026 年的 526.48 億美元,預測期內復合年增長率為 9.33%。

泌尿外科手術中出現的模式使用謹慎的設備,因為與謹慎的開放式手術相比,它具有切口更少、恢復更快、在醫療機構停留時間更短的優點。傾向於這樣做。這個市場目前的模式是顯著降低手術的複雜性,更加顯著的準確性和準確性,非常深奧和謹慎,先進和利用最先進的泌尿設備,如激光和自動輔助設備。可以獲得極好的結果,例如目的地陳述和快速恢復。

泌尿設備市場發展的主要驅動力之一是人們對需要最少麻煩的系統越來越感興趣。從長遠來看,疏忽和無憂醫療程序 (MIS) 取得了革命性的進步,改變了在工作場所執行泌尿外科策略的方法的前景。設備細心,疤痕少,疤痕少,恢復快,血液不幸和損傷更有限,在更有限的急診室,污染風險更小,一般醫療費用更低。

在泌尿外科領域,MIS 包括先進的機器、內窺鏡和腹腔鏡檢查,可到達泌尿道和相關器官,以對泌尿系統疾病進行總結、治療和管理。泌尿科醫生最常用的自動化框架是 Intuitive Surgical(美國)的達芬奇機械醫療程序框架。該系統表明市場不斷創新,因為外科醫生使用手術控制台來控制連接在機械臂上的器械,進一步推動了泌尿設備市場。

本報告調查了全球泌尿設備市場,包括市場的基本結構、主要的促進/抑制因素、整體市場規模趨勢展望,按設備/容器類型/最終用戶/地區。提供詳細的趨勢、競爭條件、主要公司的簡介等。

目錄

第 1 章介紹

  • 市場定義
  • 市場細分

第 2 章調查方法

  • 調查數據
  • 先決條件

第 3 章執行摘要

  • 研究亮點

第 4 章市場動態

  • 市場驅動因素
  • 市場限制
  • 波特五力分析
    • 供應商談判權
    • 買方的議價能力
    • 新進入者的威脅
    • 替代威脅
    • 競爭對手之間的敵對關係
  • 功能價值鏈分析

第 5 章泌尿外科器械市場分析:按器械

  • 簡介
  • 透析設備
  • 內窺鏡設備
  • 雷射光和碎石設備
  • ENDO 視覺設備
  • 其他

第 6 章泌尿外科器械市場分析:按血管類型

  • 簡介
  • 前列腺癌
  • 膀胱癌
  • 腎結石
  • 良性前列腺增生
  • 其他

第 7 章泌尿外科器械市場分析:按最終用戶

  • 簡介
  • 醫院和診所
  • 門診
  • 專科診所

第 8 章泌尿外科器械市場分析:按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 以色列
    • 沙特阿拉伯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 台灣
    • 泰國
    • 印度尼西亞
    • 其他

第 9 章競爭環境與分析

  • 主要公司和戰略分析
  • 初創企業和市場盈利能力
  • 企業併購(M&A)/合同/業務合作
  • 供應商競爭力矩陣

第 10 章公司簡介。

  • STERIS Corporation
  • Integer Holdings Corporation
  • Olympus Corporation
  • Siemens Medical Solutions
  • Boston Scientific Corporation
  • Surgical Holdings
  • Medtronic
  • Dornier MedTech
  • Stryker
  • Cook Medical
目錄
Product Code: KSI061611754

The global urology devices market is expected to grow at a compound annual growth rate of 9.33% over the forecast period to reach a market size of US$52.684 billion in 2026 from US$28.213 billion in 2019. Urology devices are clinical devices utilized for the analysis and treatment of kidney and urology infections. The arising pattern in urological surgeries is the inclination for utilization of negligibly obtrusive devices because of benefits like fewer cuts, quicker recuperation rate, and fewer medical clinic stays contrasted with open careful mediation. The present pattern in this market is the advancement and utilization of cutting-edge urology devices like laser and automated helped devices to make surgery considerably less complex with better results like more noteworthy exactness and precision, representation of mind-boggling careful destinations, and fast recovery.

Developing inclination for negligibly intrusive systems is required to be one of the major factors driving the development of the urology devices market. Throughout the long term, negligibly intrusive medical procedures (MIS) have gone through an uncommon change as far as innovative progressions, which has achieved a change in outlook in the way urological strategies are acted in working rooms. The benefits offered by negligibly obtrusive careful devices incorporate fewer scars, faster recuperation periods, more limited emergency clinic stays diminished blood misfortune and injury, a lower hazard of contamination, and decreased general medical care costs. In the urology field, MIS includes advanced mechanics, endoscopy, and laparoscopy to get to the urinary lot and related organs for a conclusion, treatment, and the executives of urological conditions. The most ordinarily utilized automated framework by urologists is the da Vinci mechanical medical procedure framework by Intuitive Surgical (US). This system utilizes a surgical console in which a surgeon controls instruments attached to mechanized arms, thus indicating the presence of constant innovation in the market, which is further expected to boost the urology devices market as well. Furthermore, taking note of the increasing demand for urology devices, companies operating in the market are undertaking various strategic actions to further increase their market share. For instance, in May 2021, Olympus Corporation, a Japanese manufacturer of optics and reprography products acquired Israeli Medical Device Company Medi-Tate. The move is said to be a strategic acquisition to expand Olympus Corporation's BPH portfolio into in-office treatment.

Growth Factors.

  • Rising elderly population.

The consistently rising population of people above the age of 65 years is also expected to contribute to the urology devices market growth. According to the United Nations (UN) data of World Population Prospects for the year 2019 highlighted that the world's population is expected to increase by two billion persons in the next 30 years, from 7.7 billion currently to 9.7 billion in 2050, and with this, the world's aging population is growing too. Due to increasing life expectancy and falling fertility levels, the UN explained that for the first time in history, individuals aged 65 or above outnumbered children under five years of age globally. Moreover, by 2050, one in six people in the world will be over the age of 65 (16%), up from one in 11 in 2019 (9%). Thus, with the increasing geriatric population, the demand for urology devices is also expected to increase, considering the increasing prevalence of kidney diseases in them.

Restraints.

  • Huge capital investment.

There is a serious level of rivalry among the market players. Just significant organizations can bear the cost of high-capital ventures just as the significant expense of R&D and assembling. This will keep new participants from entering this market. New participants in this market need to rival existing players and put themselves aside by creating imaginative item contributions. The serious level of combination goes about as a significant section boundary for new contestants, which thusly is relied upon to limit ventures and accordingly hinder the development capability of this market. The prerequisite of high-capital speculations and the significant expense of R&D and assembling will likewise prevent new players.

Impact of COVID - 19.

The COVID-19 pandemic has disrupted health systems worldwide. This has had a profound impact on urological care and urology care providers. The developing number of COVID-19 cases across the globe has immersed numerous medical services offices with fundamentally sick patients. The COVID-19 strain normally causes intense respiratory pain in patients and may bring about intense kidney injury and, now and again, kidney disappointment. As per the American Society of Nephrology, roughly 10-50% of patients with serious COVID-19 conceded to escalated care units have kidney disappointment that requires some type of dialysis. The developing instances of COVID-19-contaminated patients across the globe are expected to support the interest in dialysis strategies. Therefore, the interest in home dialysis machines has expanded attributable to the expanding inclination for home dialysis treatment because of movement limitations.

Competitive Insights.

The increasing demand for urology devices has led to the entry of several new market players like Stryker in the urology devices market. The entry of these new players in a market where traditional pharma behemoths like STERIS Corporation and Olympus Corporation already exist is expected to lead to further innovation in the urology devices market. Moreover, in order to further increase their clientele as well as increase their market share in the upcoming years, many of these market players have taken various strategic actions like partnerships and development of novel solutions which primarily focus on providing comfort to the patient, which is expected to keep the market competitive and constantly evolving.

Market Segmentation:

  • By Devices
  • Dialysis Devices
  • Endoscopic Devices
  • Lasers & Lithotripsy Devices
  • Endo vision Devices
  • Others
  • By Vessel Type
  • Prostate Cancer
  • Bladder Cancer
  • Kidney Stones
  • Benign Prostatic Hyperplasia
  • Others
  • By End-Users
  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Specialty Clinics
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Function
  • 4.4. Function Value Chain Analysis

5. Urology Devices Market Analysis, By Devices

  • 5.1. Introduction
  • 5.2. Dialysis Devices
  • 5.3. Endoscopic Devices
  • 5.4. Lasers & Lithotripsy Devices
  • 5.5. Endo vision Devices
  • 5.6. Others

6. Urology Devices Market Analysis, By Vessel Type

  • 6.1. Introduction
  • 6.2. Prostate Cancer
  • 6.3. Bladder Cancer
  • 6.4. Kidney Stones
  • 6.5. Benign Prostatic Hyperplasia
  • 6.6. Others

7. Urology Devices Market Analysis, By End-Users

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Care Centers
  • 7.4. Specialty Clinics

8. Urology Devices Market Analysis, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. Germany
    • 8.4.3. Italy
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Israel
    • 8.5.2. Saudi Arabia
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. Japan
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. South Korea
    • 8.6.6. Taiwan
    • 8.6.7. Thailand
    • 8.6.8. Indonesia
    • 8.6.9. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles.

  • 10.1. STERIS Corporation
  • 10.2. Integer Holdings Corporation
  • 10.3. Olympus Corporation
  • 10.4. Siemens Medical Solutions
  • 10.5. Boston Scientific Corporation
  • 10.6. Surgical Holdings
  • 10.7. Medtronic
  • 10.8. Dornier MedTech
  • 10.9. Stryker
  • 10.10. Cook Medical